WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
US overdose deaths dropped in 2023, the first time since 2018
Across China: Never Too Late! 66
Canada and U.S. ratchet up their cross
Georgia Republicans choose Amy Kremer, organizer of pro
Chen Yufei Wins Women's Singles Title at 2023 Indonesia Open
Chinese vice premier stresses implementation of projects funded by gov't bonds
Cunchao Attracts Billions of Views, Boosts Regional Development
Investigators return to Long Island home of Gilgo Beach serial killing suspect
Jiang Wins China's First Golds at Asian Weightlifting Championships